Gianluca Severi
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (15)
Background: Current epidemiologic evidence indicates that smoking is associated with a lower endometrial cancer risk. However, it is unknown if this association is causal or confounded. To further elucidate the role of smoking in endometrial cancer risk, we conducted complementary observational and Mendelian randomization (MR) analyses. Methods: The observational analyses included 286,415 participants enrolled in the European Prospective Investigation into Cancer and Nutrition and 179,271 participants in the UK Biobank, and multivariable Cox proportional hazards models were used. In two-sample MR analyses, genetic variants robustly associated with lifetime amount of smoking ( n = 126 variants) and ever having smoked regularly ( n = 112 variants) were selected and their association with endometrial cancer risk (12,906 cancer/108,979 controls from the Endometrial Cancer Association Consortium) was examined. Results: In the observational analysis, lifetime amount of smoking and ever having smoked regularly were associated with a lower endometrial cancer risk. In the MR analysis accounting for body mass index, a genetic predisposition to a higher lifetime amount of smoking was not associated with endometrial cancer risk (OR per 1-SD increment: 1.15; 95% confidence interval: 0.91–1.44). Genetic predisposition to ever having smoked regularly was not associated with risk of endometrial cancer. Conclusions: Smoking was inversely associated with endometrial cancer in the observational analyses, although unsupported by the MR. Additional studies are required to better understand the possible confounders and mechanisms underlying the observed associations between smoking and endometrial cancer. Impact: The results from this analysis indicate that smoking is unlikely to be causally linked with endometrial cancer risk.
Year:
2025
Background: Many studies have shown that socioeconomic position (SEP) is associated with the incidence of malignant tumors at different sites. This study aims to estimate the association between educational level (as proxy for SEP) and cancer incidence and to understand whether the observed associations might be partially explained by lifestyle behaviors. Methods: The analyses were performed on data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study, globally and by sex. We used Cox proportional hazards models together with mediation analysis to disentangle the total effect (TE) of educational level [measured through the Relative Index of Inequality (RII)] on cancer incidence into pure direct (PDE) and total indirect (TIE) effect, unexplained and explained by mediators, respectively. PDE and TIE were then combined to compute the proportions mediated (PM). Results: After an average of 14 years of follow-up, 52,422 malignant tumors were ascertained. Low educated participants showed higher risk of developing stomach, lung, kidney (in women), and bladder (in men) cancers, and, conversely, lower risk of melanoma and breast cancer (in post-menopausal women), when compared with more educated participants. Mediation analyses showed that portions of the TE of RII on cancer could be explained by site-specific related lifestyle behaviors for stomach, lung, and breast (in women). Conclusions: Cancer incidence in Europe is determined at least in part by a socioeconomically stratified distribution of risk factors. Impact: These observational findings support policies to reduce cancer occurrence by altering mediators, such as lifestyle behaviors, particularly focusing on underprivileged strata of the population.
Year:
2025
Descriptive analyses according to sex and country, Analyses to verify mediation assumptions. Supplementary Table S1 Descriptive analyses of the male EPIC population in terms of demographic, clinical, and risk/protective factors for cancer, according to the Relative Index of Inequality Tertiles (RIIT). Supplementary Table S2 Descriptive analyses of the female EPIC population in terms of demographic, clinical, and risk/protective factors for cancer, according to the Relative Index of Inequality Tertiles (RIIT). Supplementary Table S3 Descriptive analyses of the EPIC population in terms of demographic, clinical, and lifestyle risk/protective factors for cancer, according to sex and country. Supplementary Table S4 Multinomial logistic, logistic, and linear regressions results in terms of Odds Ratios (OR) or linear coefficient (beta) showing the association between the Relative Index of Inequality Tertiles (RIIT) and putative mediators. Supplementary Table S5 Cox Proportional-Hazard models showing the Hazard Ratio (HR) for the site-specific putative mediators on the incidence of the tumour at the relative site.
Year:
2025
Effects (pure direct effect, total indirect effect, and total effect) estimated as function of time to event (years), considering site-specific cancer occurrence as outcome, RelativeIndex of Inequality Tertiles (RIIT) as exposure, age, and country (and sex) as confounders, site-specific lifestyle-behavioural factors as mediators.
Year:
2025
Supplementary Table 7 shows the Mendelian randomization estimates for the potential causal effect of genetic liability to allergic diseases and asthma on colorectal cancer risk; leave one genetic variant out sensitivity analyses.
Year:
2025
Supplementary Table 4 shows the genome-wide significant variants related to (a) allergic diseases (asthma, hay fever, or eczema), (b) early-onset asthma, (c) later-onset asthma, (d) atopic asthma, and (e) hay fever or eczema and their association with other traits in previous genome-wide association studies.
Year:
2025
Supplementary Table 2 shows the genetic variant overlap (same variants or variants in LD R2>0.001 between exposures) for the three exposures tested in our Mendelian randomization analyses (i.e., genetic liability to allergic diseases and their overlap with variants associated with asthma-related phenotypes and hay fever/allergic rhinitis or eczema).
Year:
2025
Background: The tumor immunosurveillance theory supports that allergic conditions could decrease cancer risk. However, observational evidence yielded inconsistent results for the association between allergic diseases and colorectal cancer risk. We used Mendelian randomization (MR) to examine potential causal associations of allergies with the risk of overall and early-onset colorectal cancer. Methods: Genome-wide association study summary statistical data were used to identify genetic variants associated with allergic diseases ( N variants = 65) and individual allergic conditions (asthma, hay fever/allergic rhinitis, and eczema). Using two-sample MR, we examined these variants in relation to incident overall ( N cases = 52,775 cases) and early-onset colorectal cancer ( N cases = 6,176). The mediating role of white blood cells was examined using multivariable MR. Results: In inverse-variance–weighted models, genetic liability to allergic diseases was inversely associated with overall {OR per log (odds) = 0.90 [95% confidence interval (CI), 0.85–0.96]; P P = 0.01]. Similar inverse associations were found for hay fever/allergic rhinitis or eczema, whereas no evidence of association was found between liability to asthma-related phenotypes and colorectal cancer risk. Multivariable MR adjustment for eosinophils weakened the inverse associations for liability to allergic diseases for overall [OR = 0.96 (95% CI, 0.89–1.03); P = 0.26] and early-onset colorectal cancer [OR = 0.86 (95% CI, 0.73–1.01); P = 0.06]. Conclusions: Our study supports a potential causal association between liability to allergic diseases, specifically hay fever/allergic rhinitis or eczema, and colorectal cancer, possibly at least in part mediated via eosinophil counts. Impact: Our results provide evidence that allergic responses may also have a role in immunosurveillance against colorectal cancer.
Year:
2025
Supplementary Table 3 shows the number of cancer cases and controls in the Mendelian randomization study of genetic liability to allergic diseases and asthma-related phenotypes and risk of colorectal cancer.
Year:
2025
Supplementary figure S2: Flowchart recapping the different stages of the analysis The flowchart describes schematically the different stages of our analysis starting from the normalisation of the metabolomic data, the determination of the metabolomic signature in the controls and finally the derivation of the metabolomic signature in the CRC nested case control study and the evaluation of any mediating effects Abbreviations: CRC: colorectal cancer; PLS: partial least squares
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2020
Collaborators (48)
Fabian Eichelmann
German Institute of Human Nutrition
Annika Idahl
Umea University
Marc Gunter
International Agency for Research on Cancer
Konstantinos K. Tsilidis
-
Ben Lacey
-
Emma Vincent
Academic , Professor of Molecular Metabolism
University of Bristol
Naomi Allen
University of Oxford
Carlotta Sacerdote
Docenti di ruolo di Ia fascia
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Kristin Benjaminsen Borch
Associate professor and Research group leader Systems Epidemiology
UiT The Arctic University of Norway
Anne Tjonneland
Professor
Københavns Universitet
Fulvio Ricceri
University of Turin
Christina Dahm
VIP, Professor
Aarhus University
Tracy O'Mara
Team Head
QIMR Berghofer Medical Research Institute
Zhaozhong Zhu
Massachusetts General Hospital
Sophia Harlid
Umea University
Kim Overvad
Aarhus University
Matthias B. Schulze
German Institute of Human Nutrition
Wei Zheng
-
Elizabeth Platz
Professor
Johns Hopkins University
Heather Ward
Imperial College London
Sarah Lewis
Senior Lecturer
University of Bristol
Inger Torhild Gram
Professor
UiT The Arctic University of Norway
Adrian Hugo Aginagalde Llorente
Associate lecturer / profesor asociado
Universidad de Deusto
Claudia Giachino
University of Turin
Manuela Bergmann
senior scientist
German Institute of Human Nutrition
Sun-Seog Kweon
Chonnam National University
Robert C. Grant
University Health Network
Bethany Van Guelpen
Umea University
Dagfinn Aune
Associate Professor
-
Li Li
University of Virginia
Philip Haycock
Senior Lecturer in Cancer Epidemiology
University of Bristol
Xia Jiang
Karolinska Institutet
Tonje Braaten
Associate professor II
Nord University
Rebecca Richmond
Academic , Associate Professor in Molecular Epidemiology
University of Bristol
Alicia Heath
Imperial College London
Renée Fortner
Head of Division
Deutsches Krebsforschungszentrum
Vittorio Perduca
Université Paris Cité
Elom K Aglago
Imperial College London
Nicola Bondonno
Adjunct Lecturer
Edith Cowan University
Aurora Perez-Cornago
University of Oxford
Marina Kvaskoff
-
Mattias Johansson
Scientist
International Agency for Research on Cancer
Pietro Ferrari
Branch Head
International Agency for Research on Cancer
alessandra macciotta
University of Turin
Daniel D. Buchanan
Senior Research Fellow
University of Melbourne
Christopher Li
Fred Hutchinson Cancer Research Center
Domenico PALLI
Head
Institute for Cancer Research, Prevention and Clinical Network-ISPRO
Stephen Gruber
Professor
City Of Hope National Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.